 |
|
Alzheimer Disease and Mortality
A 15-Year Epidemiological Study
Mary Ganguli, MD, MPH;
Hiroko H. Dodge, PhD;
Changyu Shen, PhD;
Rajesh S. Pandav, MBBS, MPH;
Steven T. DeKosky, MD
Arch Neurol. 2005;62:779-784.
Background Alzheimer disease (AD) is considered a leading cause of death, but few studies have examined the contribution of AD to mortality based on follow-up of representative US cohorts.
Objective To examine mortality rates, duration of survival, causes of death, and the contribution of AD to the risk of mortality in an aging community-based cohort, controlling for other predictors.
Design Fifteen-year prospective epidemiological study. Mortality rates per 1000 person-years and the population-attributable risk of mortality were determined. Cox proportional hazards models were used to estimate relative risk of mortality due to AD, adjusting for relevant covariates. Death certificates were abstracted for listed causes of death.
Setting A largely blue-collar rural community in southwestern Pennsylvania.
Participants A community-based cohort of 1670 adults 65 years and older at study enrollment.
Main Outcome Measure Mortality.
Results In the overall cohort, AD was a significant predictor of mortality, with a hazard ratio of 1.4 after adjusting for covariates. The population-attributable risk of mortality from AD was 4.9% based on the same model. Examining the sexes separately, AD increased mortality risk only among women. Death certificates of AD subjects were more likely to list dementia/AD, other brain disorders, pneumonia, and dehydration, and less likely to include cancer.
Conclusions Alzheimer disease was responsible for 4.9% of the deaths in this elderly cohort. Alzheimer disease increased the risk of mortality 40% in the cohort as a whole and separately in women but not in men. The mean (SD) duration of survival with AD was 5.9 (3.7) years, and longer with earlier age at onset.
Author Affiliations: Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pa (Drs Ganguli and Dodge); and Division of Geriatrics and Neuropsychiatry, Department of Psychiatry (Drs Ganguli, Shen, Pandav, and DeKosky), and Department of Neurology and Alzheimer’s Disease Research Center (Dr DeKosky), University of Pittsburgh School of Medicine. Dr Shen is now with the Division of Biostatistics, Department of Medicine, Indiana University School of Medicine, Indianapolis. Dr Pandav is now with the South-East Asia Regional Office, World Health Organization, New Delhi, India.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Statin use and risk of community acquired pneumonia in older people: population based case-control study
Dublin et al.
BMJ 2009;338:b2137-b2137.
ABSTRACT
| FULL TEXT
Biracial Population Study of Mortality in Mild Cognitive Impairment and Alzheimer Disease
Wilson et al.
Arch Neurol 2009;66:767-772.
ABSTRACT
| FULL TEXT
MRI Biomarkers of Vascular Damage and Atrophy Predicting Mortality in a Memory Clinic Population
Henneman et al.
Stroke 2009;40:492-498.
ABSTRACT
| FULL TEXT
Residence Near Power Lines and Mortality From Neurodegenerative Diseases: Longitudinal Study of the Swiss Population
Huss et al.
Am J Epidemiol 2009;169:167-175.
ABSTRACT
| FULL TEXT
Survival in Alzheimer disease: A multiethnic, population-based study of incident cases
Helzner et al.
Neurology 2008;71:1489-1495.
ABSTRACT
| FULL TEXT
A population-based study of mortality in essential tremor
Louis et al.
Neurology 2007;69:1982-1989.
ABSTRACT
| FULL TEXT
Alzheimer's disease and anaesthesia: implications for the central cholinergic system
Fodale et al.
Br J Anaesth 2006;97:445-452.
ABSTRACT
| FULL TEXT
Serum cholesterol and risk of Alzheimer disease: A community-based cohort study
Li et al.
Neurology 2005;65:1045-1050.
ABSTRACT
| FULL TEXT
|
